IFNα treatment is used in treating chronic hepatitis B and recent cell culture studies have shown that induction of A3 and BER by IFNα treatment is essential for decreasing hepatitis B virus (39,50–52). Here, IFNA2 is linked to chronic hepatitis B virus infection.